Xtant Medical Holdings Inc (XTNT)

[JenningsB]

It amazes me that companies still use "to pursue other interests" to describe the firing of a CEO. I would guess this is related to his not dealing with the interest payment in a timely way. He did grow revenues but XTNT sales and marketing costs are extraordinary. Carl O'Connell, President with a sales background who only came on board last October, takes over in the interim. I am interested to hear what his plans are to continue to grow revenue while reducing those costs. The stock isn't selling off so this "resignation" may be viewed as a positive by those who'd been selling with both hands recently.

Xtant Medical CEO Dan Goldberger announces
By GlobeNewswire, January 23, 2017, 07:30:00 AM EDT

BELGRADE, Mont., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that on January 21, 2017, Dan Goldberger resigned as Chief Executive Officer and as a Director of the Company and its subsidiaries to pursue other interests. Current President Carl O'Connell will serve as interim CEO while the Company's Board of Directors contemplates the permanent CEO. Mr. O'Connell joined the Company in October 2016. He has previously worked in leadership roles at Wright Medical Group N.V., Calmare Therapeutics Incorporated (formerly known as Competitive Technologies), the US Healthcare Division MedSurg for ITOCHU, Stryker Spine, and Carl Zeiss Surgical.

"We are thankful for Dan's significant contributions to the Company during his tenure as Chief Executive. Under Dan's leadership, the Company has made significant progress toward our strategic goals," said Kent Swanson, Chairman of the company's Board of Directors. "We are fortunate to have Carl O'Connell agree to serve as interim CEO. Carl is an accomplished senior executive with a demonstrated history of leading marketing and sales organizations and deep healthcare and medical device experience. We look forward to working with Carl as we embark on the next phase of the Company's growth."